These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 35324718)

  • 21. Indoxyl Sulfate, a Uremic Endotheliotoxin.
    Lano G; Burtey S; Sallée M
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
    Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
    Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
    Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
    J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation.
    Liu JR; Miao H; Deng DQ; Vaziri ND; Li P; Zhao YY
    Cell Mol Life Sci; 2021 Feb; 78(3):909-922. PubMed ID: 32965514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Evolving View of Uremic Toxicity.
    Meijers B; Lowenstein J
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.
    Prokopienko AJ; Nolin TD
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):71-82. PubMed ID: 28905671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Food-Derived Uremic Toxins in Chronic Kidney Disease.
    Lauriola M; Farré R; Evenepoel P; Overbeek SA; Meijers B
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Dual Roles of Protein-Bound Solutes as Toxins and Signaling Molecules in Uremia.
    Masereeuw R
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Dental Scores and Saliva Uremic Toxins.
    Rigothier C; Catros S; Bénard A; Samot J; Quintin O; Combe C; Larabi I; Massy Z; Alvarez JC
    Toxins (Basel); 2023 Nov; 15(11):. PubMed ID: 37999529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLC22A11 Inserts the Uremic Toxins Indoxyl Sulfate and P-Cresol Sulfate into the Plasma Membrane.
    Tust M; Müller JP; Fischer D; Gründemann D
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondria as a Source and a Target for Uremic Toxins.
    Popkov VA; Silachev DN; Zalevsky AO; Zorov DB; Plotnikov EY
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kidney drug transporter OAT1 regulates gut microbiome-dependent host metabolism.
    Granados JC; Ermakov V; Maity K; Vera DR; Chang G; Nigam SK
    JCI Insight; 2023 Jan; 8(2):. PubMed ID: 36692015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Influence of OAT1 Density and Functionality on Indoxyl Sulfate Transport in the Human Proximal Tubule: An Integrated Computational and In Vitro Study.
    King J; Mihaila SM; Ahmed S; Truckenmüller R; Giselbrecht S; Masereeuw R; Carlier A
    Toxins (Basel); 2021 Sep; 13(10):. PubMed ID: 34678967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease.
    Arinze NV; Yin W; Lotfollahzadeh S; Napoleon MA; Richards S; Walker JA; Belghasem M; Ravid JD; Hassan Kamel M; Whelan SA; Lee N; Siracuse JJ; Anderson S; Farber A; Sherr D; Francis J; Hamburg NM; Rahimi N; Chitalia VC
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34752422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indoxyl glucuronide, a protein-bound uremic toxin, inhibits hypoxia-inducible factor‒dependent erythropoietin expression through activation of aryl hydrocarbon receptor.
    Asai H; Hirata J; Watanabe-Akanuma M
    Biochem Biophys Res Commun; 2018 Oct; 504(2):538-544. PubMed ID: 30205954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.